返回
Qyuns Therapeutics Co., Ltd.（02509.HK）價格
02509.HK 股價走勢圖
QYUNS-B (02509.HK)
Qyuns Therapeutics Co., Ltd.
HK$22.96
-1.11%
$-0.25
休市： Jan 16, 16:00:00 HKT
關鍵數據
前收市價
$23.3
開盤價
$23.22
當日範圍
$22.8 - $23.68
52週區間
$5.95 - $36.5
交易量
131.0K
平均成交量
507.1K
每股盈餘 (TTM)
-0.97
股息收益率
--
市值
$5.1B
什麼是 QYUNS-B？
Qyuns Therapeutics Co., Ltd. is a clinical biopharmaceutical company focusing on biotherapeutics for autoimmune and allergic diseases. The company is headquartered in Taizhou, Jiangsu and currently employs 337 full-time employees. The company went IPO on 2024-03-20. The firm is mainly engaged in biotechnology research and development of biological therapies for autoimmune and allergic diseases. The firm's business mainly covers four major disease areas, including skin, rheumatism, respiratory and digestive tract diseases. The firm is developing eight projects, with target indications including psoriasis, atopic dermatitis, rheumatoid arthritis, inflammatory bowel disease and asthma. The firm's core products include QX002N and QX005N.
